This compound is a benzimidazole derivative featuring a difluorinated chromane ether side chain. It is primarily utilized as a research reagent in pharmaceutical development, with its structure suggesting potential for studying receptor interactions or biochemical pathways.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2351939-46-1
7-[(5,7-Difluorochroman-4-yl)oxy]-2-methyl-1H-benzo[d]imidazole-5-carboxylic Acid
Pharmaceutical intermediate
Tegoprazan
potassium-competitive acid blocker
(4R)-Tegoprazan
active pharmaceutical ingredient
Loratadine N-Oxide
pharmaceutical research compound
4-(4-Cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxamide
pharmaceutical research compound
1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride
pharmaceutical research compound
Benzoic acid, 4-(2-(octyloxy)benzamido)-, 2-(diethylamino)ethyl ester hydrochloride
pharmaceutical research compound
N-isopropyl-2-nitrobenzenesulfonamide
research compound
7-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-N,2-dimethyl-3H-benzimidazole-5-carboxamide
XSFQYWLWWMLNHM-UHFFFAOYSA-N
CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)NC